Unable to display view head.php file not found.
 
 

William French, MD - Anticoagulation: Special Populations - Figure 12

Risk Factors and Efficacy

After the greater risk of thromboembolism in women seen in the previous Figure, the good news in this Figure, from a pooled analysis of 5 randomized trials,[128] is that anticoagulation therapy with warfarin decreased the risk of stroke by 84% in women compared with only 60% in men.  So importantly, the chance of a woman with AFib having a stroke or systemic emboli is higher, but the use of antithrombin therapy actually seems to confer greater benefit to females even than for men.

French WJ. Am J Med 2013; 126: 00-00.

Complete references for all slides

References

[128] Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-1457.

Unable to display view foot.php file not found.